Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2013 Oct:24 Suppl 6:vi7-23. doi: 10.1093/annonc/mdt284. Epub 2013 Aug 22.

Authors

E Senkus¹, S Kyriakides, F Penault-Llorca, P Poortmans, A Thompson, S Zackrisson, F Cardoso; ESMO Guidelines Working Group

Affiliation

¹ Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.

PMID: 23970019
DOI: 10.1093/annonc/mdt284

No abstract available

Publication types

Practice Guideline

MeSH terms

Aging
BRCA1 Protein / genetics
BRCA2 Protein / genetics
Biomarkers, Tumor / metabolism
Breast Neoplasms / diagnosis*
Breast Neoplasms / epidemiology
Breast Neoplasms / therapy*
Breast Neoplasms, Male / epidemiology
Carcinoma in Situ / diagnosis
Carcinoma in Situ / epidemiology
Carcinoma in Situ / therapy
Chemotherapy, Adjuvant
Early Detection of Cancer / methods*
Europe / epidemiology
Female
Follow-Up Studies
Humans
Ki-67 Antigen / metabolism
Lymphatic Metastasis / diagnosis
Male
Mastectomy, Segmental / methods*
Neoplasm Recurrence, Local / therapy
Neoplasm Staging
Radiotherapy, Adjuvant
Receptor, ErbB-2 / metabolism
Receptors, Estrogen / metabolism
Receptors, Progesterone / metabolism
Risk Assessment

Substances

BRCA1 Protein
BRCA1 protein, human
BRCA2 Protein
BRCA2 protein, human
Biomarkers, Tumor
Ki-67 Antigen
Receptors, Estrogen
Receptors, Progesterone
ERBB2 protein, human
Receptor, ErbB-2